Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|September 18, 2023
Development of Novel Trifunctional Chelating Agents That Enhance Tumor Retention of RadioimmunoconjugatesKazuma Nakashima, Hiroyuki Watanabe, Masahiro Ono
Chemical Communications (Cambridge, England)|February 16, 2026
Dual pharmacokinetic modifier strategy for synergistically enhanced tumor accumulation of PSMA-targeting radioligandTakuma Hasegawa, Kazuma Nakashima, Hiroyuki Watanabe, et al.
Journal of Medicinal Chemistry|October 27, 2025
Structure-Activity Relationships of Azaquinazolinone Derivatives as 18F-Labeled PET Probes Targeting Ghrelin ReceptorsHiroyuki Watanabe, Haruka Saito, Kazuma Nakashima, et al.
ACS Medicinal Chemistry Letters|May 14, 2025
Development of Novel Gastrin-Releasing Peptide Receptor-Targeted Radioligand with Albumin Binder to Improve Accumulation in TumorShohei Tsuchihashi, Kazuma Nakashima, Hiroyuki Watanabe, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|August 6, 2024
Application of Microfluidic Devices for Automated Two-Step Radiolabeling of AntibodiesHiroki Jinda, Hiroyuki Watanabe, Kazuma Nakashima, et al.
ACS Medicinal Chemistry Letters|July 16, 2025
Development of Novel Integrin αvβ3‑Targeted Radioligand for Enhanced Tumor AccumulationNobuki Kazuta, Kazuma Nakashima, Hiroyuki Watanabe, et al.
ACS Medicinal Chemistry Letters|April 16, 2025
Preclinical Characterization of Novel FAP-2286-Based Radioligand with Albumin Binder for Improved Tumor RetentionKosuke Saito, Hiroyuki Watanabe, Kazuma Nakashima, et al.
ACS Pharmacology & Translational Science|June 18, 2026
Head-to-Head Comparison of Monomeric, Homodimeric, and Heterodimeric Fibroblast Activation Protein-Targeting Radioligands Based on Small Molecule Inhibitor and Cyclic PeptideKosuke Saito, Hiroyuki Watanabe, Kazuma Nakashima, et al.
Frontiers in Nuclear Medicine|May 1, 2025
Comparison of carbonic anhydrase-IX-targeted trifunctional radioligands between linear- and branched-chain arrangementsKazuma Nakashima, Takayoshi Ichinose, Hiroyuki Watanabe, et al.
Chemical Communications (Cambridge, England)|June 7, 2021
Development of a novel radiotheranostic platform with a DOTA-based trifunctional chelating agentKazuma Nakashima, Shimpei Iikuni, Hiroyuki Watanabe, et al.
Pageof 3